Fomepizole

CHEMBL1308 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
82.1 g/mol
LogP
1.4
Phase
4

This medication works by blocking the enzyme alcohol dehydrogenase, preventing the body from converting methanol or ethylene glycol into toxic metabolites that can cause blindness, kidney failure, and death. It is used as an antidote in emergency treatment of methanol and antifreeze poisoning.

Peso molecular

82,1000 g/mol

LogP

1,40

TPSA

28,70 Ų

Regla de cinco de Lipinski

Cumple

Mecanismo de acción

Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cn[nH]c1

InChI

InChI=1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6)

Molecular Formula

C4H6N2

HBD / HBA

1 / 1

Enlaces Rotables

0

Átomos Pesados

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This medication works by blocking the enzyme alcohol dehydrogenase, preventing the body from converting methanol or ethylene glycol into toxic metabolites that can cause blindness, kidney failure, and death. It is used as an antidote in emergency treatment of methanol and antifreeze poisoning.

Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.

Yes, Fomepizole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1308. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3406. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.